Literature DB >> 26261549

Effects of targeted nano-delivery systems combined with hTERT-siRNA and Bmi-1-siRNA on MCF-7 cells.

Lei Liu1, Huixiang Li1, Min Zhang1, Xinquan Lv1.   

Abstract

The aim of this study was to evaluate the efficiency of a targeted siRNA nano-delivery system to silence the expression of Bmi-1 and hTERT, and to verify the toxicity of this delivery system in MCF-7 breast cancer cells. The most effective Bmi-1 siRNA and hTERT siRNA sequences were selected using RT-PCR and Western blotting. The polyethyleneimine (PEI)/siRNA nano-condensate was synthesized using PEI and modified using an NGR peptide fragment for targeting to tumor cells. The vector morphology, particle size and zeta potential were observed using an atomic force microscope and a laser particle size analyzer. The MCF-7 breast cancer cell line was transfected with the vector, and cytotoxicity was tested by MTT assays. The transfection efficiency was evaluated by qRT-PCR and Western blotting. Changes in gene expression and apoptosis rate were measured by flow cytometry. The size of LPN carrier and the condensate particle was between 100 and 200 nm and the potentials were close to neutral. There was maximum transfection efficiency and no significant increase in toxicity at 15 pmol/L. Bmi-1 and hTERT expression decreased, but the inhibition rate increased in the hTERT siRNA group, the hTERT+Bmi-1 siRNA group and the hTERT+Bmi-1 siRNA group compared with the scrambled siRNA group and the control group. Moreover, the hTERT+Bmi-1 siRNA group had the highest level of gene silencing. The complex, composed of Lipo, PEI and siRNA, is low toxicity and efficient transfection vectors. The expression level of Bmi-1 and hTERT was decreased by the gene silencing of either Bmi-1 or hTERT, but the effects were more significant when both were silenced simultaneously.

Entities:  

Keywords:  Bmi-1; Breast cancer; MCF-7; PEI; nano-delivery system; siRNA

Mesh:

Substances:

Year:  2015        PMID: 26261549      PMCID: PMC4525883     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

1.  A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob.

Authors:  H Mizuguchi; N Koizumi; T Hosono; N Utoguchi; Y Watanabe; M A Kay; T Hayakawa
Journal:  Gene Ther       Date:  2001-05       Impact factor: 5.250

2.  Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas.

Authors:  H W M van Laarhoven; G Gambarota; A Heerschap; J Lok; I Verhagen; A Corti; S Toma; C Gallo Stampino; A van der Kogel; C J A Punt
Journal:  Invest New Drugs       Date:  2006-01       Impact factor: 3.850

3.  Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions.

Authors:  R D Ramirez; C P Morales; B S Herbert; J M Rohde; C Passons; J W Shay; W E Wright
Journal:  Genes Dev       Date:  2001-02-15       Impact factor: 11.361

4.  Combined introduction of Bmi-1 and hTERT immortalizes human adipose tissue-derived stromal cells with low risk of transformation.

Authors:  Péter Tátrai; Áron Szepesi; Zsolt Matula; Anna Szigeti; Gyöngyi Buchan; András Mádi; Ferenc Uher; Katalin Német
Journal:  Biochem Biophys Res Commun       Date:  2012-04-25       Impact factor: 3.575

5.  Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells.

Authors:  Flavio Curnis; Gianluigi Arrigoni; Angelina Sacchi; Lucia Fischetti; Wadih Arap; Renata Pasqualini; Angelo Corti
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

6.  BMI-1 is highly expressed in M0-subtype acute myeloid leukemia.

Authors:  Masashi Sawa; Kazuhito Yamamoto; Toshiya Yokozawa; Hitoshi Kiyoi; Asahi Hishida; Tomohiro Kajiguchi; Masao Seto; Akio Kohno; Kunio Kitamura; Yoshie Itoh; Norio Asou; Nobuyuki Hamajima; Nobuhiko Emi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

7.  Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene.

Authors:  N M van der Lugt; J Domen; K Linders; M van Roon; E Robanus-Maandag; H te Riele; M van der Valk; J Deschamps; M Sofroniew; M van Lohuizen
Journal:  Genes Dev       Date:  1994-04-01       Impact factor: 11.361

8.  Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.

Authors:  T Kiyono; S A Foster; J I Koop; J K McDougall; D A Galloway; A J Klingelhutz
Journal:  Nature       Date:  1998-11-05       Impact factor: 49.962

9.  Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas.

Authors:  Carly Leung; Merel Lingbeek; Olga Shakhova; James Liu; Ellen Tanger; Parvin Saremaslani; Maarten Van Lohuizen; Silvia Marino
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

10.  New tumor-targeted nanosized delivery carrier for oligonucleotides: characteristics in vitro and in vivo.

Authors:  Tianyang Zhou; Xin Jia; Huixiang Li; Jin Wang; Hongling Zhang; Youmei A; Zhenzhong Zhang
Journal:  Int J Nanomedicine       Date:  2011-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.